Strota/ Newsroom/ 2026-07-20

AGARWALEYE (AGARWALEYE): Acquisition / M&A

Strota Newsroom · session of 2026-07-20 · 20 Jul 17:32 · AGARWALEYE stock page →

Newspaper Advertisement of the Notice of hearing of the Company's Petition in relation to the Scheme of amalgamation bet… Historically, acquisition / m&a events have moved AGARWALEYE-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Dr. Agarwal's Health Care Ltd (NSE: AGARWALEYE) has disclosed a newspaper advertisement regarding a notice of hearing for a scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited, according to an NSE exchange filing dated 20 July 2026. The filing indicates the company has petitioned for approval of the merger arrangement, with the hearing notice now published.

Events like this acquisition or amalgamation have historically shown a 48.9% win rate across 141 comparable instances in Strota's database, with a net edge of 0.213%. This base rate reflects how similar corporate restructuring announcements have performed in the past, not a forecast for this specific stock.

The company currently trades at a price-to-earnings ratio of 115.96 and a price-to-book ratio of 7.6, with a return on equity of 8.3% and earnings per share of ₹4.18. Its market capitalisation stands at ₹15,366 crore. The Nifty declined 0.39% on the session.

The filing confirms the procedural step of the amalgamation hearing notice. It does not establish whether regulatory or shareholder approvals will follow, nor does it indicate the financial terms or strategic rationale of the merger.

The catalyst

Newspaper Advertisement of the Notice of hearing of the Company's Petition in relation to the Scheme of amalgamation between Dr. Agarwal s Eye Hospital Limited and Dr. Agarwal s Health Care Limited, is enclosed. (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

AGARWALEYE right now

P/E 115.96. Full AGARWALEYE analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.